Structure Therapeutics Inc.
GPCRNASDAQ🇺🇸Healthcare · Biotechnology
Last updated: 20h ago
52-Week Range
Company Overview
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule ago
Valuation
Profitability
Growth & Stability
Dividends
Trading Info
Related News
[StockHub Alert] Sharp Rise 5, Sharp Drop 3
🚀 Sharp Rise • BioCryst Pharmaceuticals, Inc. ($BCRX) $9.25 +12.5% • Structure Therapeutics Inc. ($GPCR) $59.20 +10.1% • Bitdeer Technologies Group ($BTDR) $8.22 +9.6% • Olema Pharmaceuticals, Inc. ($OLMA) $15.98 +8.6% • SolarEdge Technologies, Inc. ($SEDG) $40.46 +8.1% 💥 Sharp Drop • 10x Genomics, Inc. ($TXG) $16.40 -12.7% • Preformed Line Products Company ($PLPC) $246.11 -5.9% • Lindsay Corporation ($LNN) $119.01 -5.1%
[StockHub Alert] Sharp Rise 5, Sharp Drop 5
🚀 Sharp Rise • BioCryst Pharmaceuticals, Inc. ($BCRX) $9.17 +11.6% • BellRing Brands, Inc. ($BRBR) $18.41 +9.4% • Spyre Therapeutics, Inc. ($SYRE) $43.59 +9.3% • Structure Therapeutics Inc. ($GPCR) $58.57 +9.0% • Veradermics, Incorporated ($MANE) $56.85 +7.7% 💥 Sharp Drop • 10x Genomics, Inc. ($TXG) $15.97 -15.0% • Standard Lithium Ltd. ($SLI) $3.90 -8.7% • Lithium Argentina AG ($LAR) $6.25 -7.5% • Generate Biomedicines, Inc. ($GENB) $12.14 -7.2% • Evolution Metals & Technologies ($EMAT) $7.35 -5.8%